A detailed history of Agf Investments LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Agf Investments LLC holds 11,560 shares of BHVN stock, worth $541,354. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,560
Previous 6,651 73.81%
Holding current value
$541,354
Previous $969,000 80.39%
% of portfolio
0.16%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$144.95 - $152.29 $711,559 - $747,591
4,909 Added 73.81%
11,560 $1.75 Million
Q2 2022

Aug 12, 2022

BUY
$83.14 - $145.99 $29,930 - $52,556
360 Added 5.72%
6,651 $969,000
Q1 2022

May 10, 2022

SELL
$110.08 - $142.92 $76,395 - $99,186
-694 Reduced 9.94%
6,291 $746,000
Q4 2021

Feb 01, 2022

BUY
$99.73 - $148.48 $696,614 - $1.04 Million
6,985 New
6,985 $963,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.36B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.